How Covid-19 is affecting FDI regulations
Following the Covid-19 outbreak, many governments tightened FDI regulations related to critical assets. Investment Monitor rounds up the key moves.
Life sciences
Life sciences
Realising Europe’s green hydrogen potential
A report from the European Commission sets out how green hydrogen will be key to the energy transition, although it is not clear how its production will be paid for.
Ahead of the trends: How Costa Rica is creating value with purpose in a post-pandemic world
Partnership content: Leaders from the Costa Rican Investment Promotion Agency, the World Trade Organisation (WTO), Intel and Accenture discuss why Costa Rica is particularly attractive to investors at a time of global financial uncertainty.
A science lesson in secure investing
Before the onset of Covid-19 the life sciences sector was experiencing high levels of investment and rapid innovation. Months into the pandemic, the sector remains secure, but for how long will this last?
Where now for British manufacturing?
The health of the UK’s manufacturing industry was a key topic in the run-up to the country’s Brexit vote. Various sectors are coping with the twin threats of a final departure from the EU and the Covid-19 pandemic.
Stimulus packages set to give developed countries post-Covid advantage
Developing countries will face greater challenges to restarting their economies compared with their wealthy counterparts, based on the relative sizes of their Covid-19 stimulus packages.
Pharma FDI in the times of Covid-19: A challenging pill to swallow
With supply chains disrupted and the world veering all its attention towards halting Covid-19, FDI flows into the pharmaceutical sector will strongly depend on countries’ ability to respond to the epidemic, and their overall stability.
